ASCO GU 2016: Highlights

Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets

From genotype to molecular phenotype by proteomics

ER and FGFR1 interaction critical in endocrine resistant breast cancer

Interrupting breast cancer treatment for young women who desire pregnancy

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Treating women with endocrine-resistant HR /HER2 advanced breast cancer

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Estrogen receptor mutations detected in plasma associated with worse overall survival in metastatic breast cancer

Analysis of blood samples finds ESR1 gene mutations are prevalent and associated with worse overall survival

Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer

Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy